Olink Bioscience and Abnova signs co-marketing agreement to promote unique target-specific assays for cell signaling studies

Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets

Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge BioM ... more

Olink Bioscience and Abnova signs co-marketing agreement to promote unique target-specific assays for cell signaling studies

Olink Bioscience and Abnova Corporation announced a co-development and co-marketing agreement. This collaboration will address the unmet need for high-performance assays for studies of protein phosphorylation and protein interactions by combining Abnova´s growing collection of antibodies wi ... more

Olink Bioscience and Multisciences Biotech sign distributorship agreement for the Chinese market.

Olink Bioscience has signed a distributorship agreement with the Chinese distributor Multisciences Biotech Co., Ltd for distribution of the Duolink® product line in China. "Multisciences Biotech, a widely recognized company for its high quality technical support, professionalism, and distr ... more

Olink Bioscience and Abnova signs co-marketing agreement to promote unique target-specific assays for cell signaling studies

Olink Bioscience and Abnova Corporation announced a co-development and co-marketing agreement. This collaboration will address the unmet need for high-performance assays for studies of protein phosphorylation and protein interactions by combining Abnova´s growing collection of antibodies wi ... more